Drug Shortage Report for PMS-LOSARTAN-HCTZ
Report ID | 49747 |
Drug Identification Number | 02392232 |
Brand name | PMS-LOSARTAN-HCTZ |
Common or Proper name | LOSARTAN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 12.5MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-05-30 |
Actual start date | 2018-06-04 |
Estimated end date | 2019-06-04 |
Actual end date | 2019-06-28 |
Shortage status | Resolved |
Updated date | 2019-06-29 |
Company comments | RESOLVED |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-05-18 | English | Compare |
v2 | 2018-05-18 | French | Compare |
v3 | 2018-05-31 | English | Compare |
v4 | 2018-06-06 | English | Compare |
v5 | 2018-06-06 | French | Compare |
v6 | 2018-07-13 | English | Compare |
v7 | 2018-07-13 | French | Compare |
v8 | 2018-08-24 | English | Compare |
v9 | 2018-08-24 | French | Compare |
v10 | 2018-11-29 | English | Compare |
v11 | 2018-11-29 | French | Compare |
v12 | 2019-01-16 | English | Compare |
v13 | 2019-01-16 | French | Compare |
v14 | 2019-03-29 | English | Compare |
v15 | 2019-03-29 | French | Compare |
v16 | 2019-05-09 | English | Compare |
v17 | 2019-05-09 | French | Compare |
v18 | 2019-06-11 | English | Compare |
v19 | 2019-06-11 | French | Compare |
v20 | 2019-06-28 | English | Compare |